ArticleEuropean archives of psychiatry and clinical neuroscience2026
Influence of recent cannabis use on altered spectral entropy modulation and connectivity strength in patients with psychosis.
Article in European archives of psychiatry and clinical neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advancing the understanding of psychosis: integrating trauma, substance use, and neurobiological evidence.European archives of psychiatry and clinical neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Cannabis use is highly prevalent in individuals with psychosis, raising concerns about its influence on brain function. Electroencephalography (EEG) studies have identified alterations in brain activity in psychosis, including changes in spectral entropy (SE) modulation and connectivity strength (CS). However, the degree to which cannabis use contributes to these alterations remains unclear. This study investigated the effects of recent cannabis use on specific EEG measures previously found to be altered in psychosis: (i) SE modulation, (ii) pre-stimulus theta and broadband CS, and (iii) baseline CS in the gamma band. We focused specifically on the immediate effects of recent cannabis use, without considering factors like tetrahydrocannabinol content, frequency of use, or age of onset. We included 93 patients with psychosis (32 recent cannabis users, 61 non-users) and 86 age- and sex-matched healthy controls (HC; all non-users). Recent cannabis use was defined as any consumption within the past week, assessed through a clinical interview and confirmed by urinalysis. Patients had diagnosis of schizophrenia or bipolar disorder. EEG data were recorded during a P300 task, and SE modulation and baseline CS were calculated. Both patient groups (cannabis users and non-users) exhibited significantly impaired SE modulation and elevated gamma and broadband CS, compared to HC. Crucially, no significant differences were found between the two patient groups in any of the EEG measures. Recent cannabis use does not appear to be the primary driver of the observed electrophysiological alterations in psychosis. Impaired SE modulation and increased CS are likely core features of psychosis itself, independent of recent cannabis exposure. This suggests that these EEG abnormalities may represent underlying vulnerability markers for psychosis. However, further research is needed to explore the potential long-term and early-onset effects of cannabis use on brain function in individuals with psychosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.